Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Muzahir H. Tayebjee, Sunil Nadar, Andrew D. Blann, D. Gareth Beevers, Robert J. MacFadyen, Gregory Y.H. Lip

نتاج البحث: المساهمة في مجلةArticleمراجعة النظراء

129 اقتباسات (Scopus)

بصمة

أدرس بدقة موضوعات البحث “Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)'. فهما يشكلان معًا بصمة فريدة.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry